🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders

Advanced Science(2023)10.1002/advs.202206910Source: DataRank Database

Developing Hypoimmunogenic Human iPSC‐Derived Oligodendrocyte Progenitor Cells as an Off‐The‐Shelf Cell Therapy for Myelin Disorders is a research paper published in Advanced Science (2023). On theSindex it has a DataRank of 0.520. It has been cited 31 times.

N/A

0.520DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (25)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.520

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (14)

Jianfei Chao,Peng Ye ORCID,Qui Luong,Guoqiang Sun ORCID,Wei Liu ORCID

Live enrichment

PubMed:37271923

California Institute for Regenerative Medicine

Grant: TRAN1‐08525

NCI NIH HHS

Grant: P30 CA033572

NINDS NIH HHS

Grant: U01 NS122101

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202206910

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202206910

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10427412/pdf/ADVS-10-2206910.pdf

repositoryhttps://doaj.org/article/09dd6e46f2554eef892a2a30ee48afbe

Fields of Study

HumansMiceAnimalsMyelin SheathInduced Pluripotent Stem CellsOligodendrocyte Precursor CellsOligodendrogliaMultiple SclerosisCanavan Disease

MeSH Terms

HumansMiceAnimalsMyelin SheathInduced Pluripotent Stem CellsOligodendrocyte Precursor CellsOligodendrogliaMultiple SclerosisCanavan Disease

Keywords

Canavan diseaseallogeneic cell therapydemyelinating diseasesiPSCsoff-the-shelf cell therapyoligodendrocyte progenitor cells (OPC)universal donor